PenIpamorelin 10 mg
A selective GHRP studied for growth-hormone release and recovery research.
GHRP-6 PENMetabolic · GH secretagogue
A hexapeptide growth-hormone-releasing peptide (GHRP) studied for stimulating GH release through the growth-hormone secretagogue receptor, with appetite and gastric-motility endpoints in research models.
Available to authenticated researchers. Pricing and the batch Certificate of Analysis are shared on request.
GHRP-6 is a synthetic hexapeptide (His-D-Trp-Ala-Trp-D-Phe-Lys) studied as an agonist at the growth-hormone secretagogue receptor, stimulating pulsatile GH release alongside a marked appetite signal. It is frequently paired with a GHRH such as CJC-1295 in GH-axis research models. A separate strand of the literature studies it for GH-independent cytoprotective signalling through the CD36 scavenger receptor, in tissue-repair and fibrosis models.
Features
GHRP-6 is supplied in the NADOVA LABS GoQuick pre-filled pen — a graduated, ready-to-use subcutaneous delivery format that removes reconstitution and simplifies repeat-dose study designs. Each pen is prepared from HPLC-verified material, dose-marked on the barrel, and shipped refrigerated with a Certificate of Analysis available per batch.
Handling & compliance
This pre-filled pen is intended strictly for in-vitro and laboratory research. It is not a drug, supplement, or medical device, and is not for human use. Store refrigerated at 2–8 °C, protect from light, and follow accepted laboratory practice; exact specifications for your lot are listed on its Certificate of Analysis.
PenA selective GHRP studied for growth-hormone release and recovery research.
PenA GHRH analog studied for sustained growth-hormone-axis stimulation research.
PenThe 10 mg GHRH-analog pen for GH-axis and visceral-fat research.
Request a researcher account to view the Certificate of Analysis for this lot and place an order with the lab.